Canada Life’s Adverum Biotechnologies ADVM Stock Holding History

Canada Life’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-387	Closed	-$8K	–	2503
2021 Q3	$8K	Hold	387	–	–	﹤0.01%	2513
2021 Q2	$13K	Hold	387	–	–	﹤0.01%	2528
2021 Q1	$38K	Hold	387	–	–	﹤0.01%	2374
2020 Q4	$42K	Hold	387	–	–	﹤0.01%	2342
2020 Q3	$40K	Hold	387	–	–	﹤0.01%	2231
2020 Q2	$80K	Hold	387	–	–	﹤0.01%	2113
2020 Q1	$38K	Hold	387	–	–	﹤0.01%	2206
2019 Q4	$44K	Buy	+387	New	+$34.1K	﹤0.01%	2304
2015 Q4	–	Sell	-194	Closed	-$16K	–	2448
2015 Q3	$16K	Hold	194	–	–	﹤0.01%	2344
2015 Q2	$31K	Hold	194	–	–	﹤0.01%	2372
2015 Q1	$78K	Buy	+194	New	+$82K	﹤0.01%	1933

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Canada Life's ADVM Position: Q4 2021 in Review

Canada Life sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 387 shares — an estimated $8K sold.

Canada Life first reported a position in ADVM in Q1 2015 and held it in 11 quarters. The position peaked at $80K in Q2 2020. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

Canada Life reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
Canada Life sold 387 Adverum Biotechnologies shares in Q4 2021, an estimated $8K.
Canada Life first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 11 quarters.
Canada Life's Adverum Biotechnologies position peaked at $80K in Q2 2020.
98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.